Su M. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
ASO Visual Abstract: Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer.
Journal: Annals of surgical oncology
Published: July 23, 2026
Prognostic factors and the role of GnRHa in premenopausal HR+/HER2+ breast cancer achieving pathologic complete response after neoadjuvant chemotherapy.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 28, 2026
Early Oncologic Outcomes of Robot-Assisted Versus Conventional Nipple-Sparing Mastectomy: A Propensity Score-Matching Analysis.
Journal: Annals of surgical oncology
Published: February 02, 2026
Long-term Outcomes of Slowly Proliferating Luminal A-like Invasive Lobular Carcinoma Versus Invasive Carcinoma of No Special Type.
Journal: Journal of breast cancer
Published: February 01, 2026
Association between asymptomatic detection of distant metastases and survival in breast cancer: a retrospective cohort study.
Journal: BMC women's health
Published: November 18, 2025
Clinical Outcomes of Lobular Carcinoma In Situ: Risk of Invasive Cancer Development.
Journal: Journal of breast cancer
Published: November 02, 2025
Clinical Outcomes of Lobular Carcinoma In Situ: Risk of Invasive Cancer Development.
Journal: Journal of breast cancer
Published: November 02, 2025
Perceived financial toxicity after active treatment and its association with clinical outcomes among breast cancer survivors: A prospective cohort study.
Journal: Breast (Edinburgh, Scotland)
Published: October 21, 2025
A Practical Immunohistochemistry-Based Model for Predicting Pathologic Complete Response in Estrogen Receptor-Strong Positive and HER2-Negative Breast Cancer.
Journal: Journal of breast cancer
Published: September 29, 2025
Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer.
Journal: Annals of surgical oncology
Published: September 18, 2025
Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete response.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: July 25, 2025
Effect of adjuvant endocrine therapy on recurrence and contralateral breast cancer in HR-positive DCIS after mastectomy.
Journal: Breast (Edinburgh, Scotland)
Published: July 02, 2025
Last Updated: 09/26/2026